StockData
CTT Pharmaceutical Holdings, Inc. logo

CTT Pharmaceutical Holdings, Inc. (CTTH) stock

CTTHOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2015, quý kết thúc ngày Sep 30, 2015Last filing: 10-Q on Nov 18, 2026
$0.06−0.00 (-0.17%)

Close on Oct 16, 2026Market cap $1.26MP/E –Yield –

CTT Pharmaceutical ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

CTT Pharmaceutical's ebitda for the twelve months ending Dec 31, 2011 was -$757.94K. For fiscal 2011 it was -$757.94K.

Annual ebitda

PeriodPeriod endValueChange
FY2011Dec 31, 2011-$757.94K–
FY2010Dec 31, 2010-$2.00M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2011Dec 31, 2011-$186.89K–
Q3 FY2011Sep 30, 2011-$107.42K–
Q4 FY2010Dec 31, 2010-$564.55K–
Q3 FY2010Sep 30, 2010-$957.12K–
Q2 FY2010Jun 30, 2010-$361.12K–

More CTT Pharmaceutical figures

See a number that looks wrong?